These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28780407)

  • 21. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
    Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
    PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoporous microneedle arrays seamlessly connected to a drug reservoir for tunable transdermal delivery of memantine.
    Vos PJ; Kuijt N; Kaya M; Rol S; van der Maaden K
    Eur J Pharm Sci; 2020 Jul; 150():105331. PubMed ID: 32470845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
    Jeong HR; Lee HS; Choi IJ; Park JH
    J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin.
    Yan L; Raphael AP; Zhu X; Wang B; Chen W; Tang T; Deng Y; Sant HJ; Zhu G; Choy KW; Gale BK; Prow TW; Chen X
    Adv Healthc Mater; 2014 Apr; 3(4):555-64. PubMed ID: 24173960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals.
    Nguyen HX; Nguyen CN
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity.
    Ingrole RSJ; Azizoglu E; Dul M; Birchall JC; Gill HS; Prausnitz MR
    Biomaterials; 2021 Jan; 267():120491. PubMed ID: 33217629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controllable coating of microneedles for transdermal drug delivery.
    Chen J; Qiu Y; Zhang S; Yang G; Gao Y
    Drug Dev Ind Pharm; 2015 Mar; 41(3):415-22. PubMed ID: 24378200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy.
    Gowda BHJ; Ahmed MG; Sahebkar A; Riadi Y; Shukla R; Kesharwani P
    Biomacromolecules; 2022 Apr; 23(4):1519-1544. PubMed ID: 35274937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery.
    Roxhed N; Griss P; Stemme G
    Biomed Microdevices; 2008 Apr; 10(2):271-9. PubMed ID: 17940907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success.
    Caffarel-Salvador E; Donnelly RF
    Curr Pharm Des; 2016; 22(9):1105-17. PubMed ID: 26675227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-dermal applications of microneedle drug delivery systems.
    Panda A; Matadh VA; Suresh S; Shivakumar HN; Murthy SN
    Drug Deliv Transl Res; 2022 Jan; 12(1):67-78. PubMed ID: 33629222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Versatile Ice Microneedles for Transdermal Delivery of Diverse Actives.
    Zhang X; Fu X; Chen G; Wang Y; Zhao Y
    Adv Sci (Weinh); 2021 Sep; 8(17):e2101210. PubMed ID: 34218532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
    Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
    Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research hotspot and trend of microneedles in biomedical field: A bibliometric analysis from 2011 to 2020.
    Chen X; Xiao H; Zhao Q; Xu X; Cen Y; Xiao D
    Burns; 2022 Jun; 48(4):959-972. PubMed ID: 35504768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery.
    Song HB; Lee KJ; Seo IH; Lee JY; Lee SM; Kim JH; Kim JH; Ryu W
    J Control Release; 2015 Jul; 209():272-9. PubMed ID: 25937320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.